News
-
-
PRESS RELEASE
aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
aap Implantate AG reports €6.2 million sales in the first half of 2025, with clinical trial near positive conclusion. Regional growth in EMEA, strong performance in APAC, US tariff impact mitigated -
-
-
-
PRESS RELEASE
aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
aap Implantate AG announces full admission of previously unadmitted shares to the Frankfurt Stock Exchange's regulated market, along with the termination of lock-up agreements -
-
PRESS RELEASE
aap Implantate AG publishes final audited consolidated financial statements 2024 - confirmation of strong operational improvement
aap Implantate AG publishes final audited consolidated financial statements 2024, confirming strong operational improvement. The company achieved a significant increase in Group EBITDA -
-
PRESS RELEASE
aap Implantate AG closes financial year 2024 successfully - positive developments despite challenging environment
aap Implantate AG successfully closes financial year 2024 with positive developments, achieving sales growth and strengthening market position, especially in EMEA and LATAM regions
